secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001493152-25-004329
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health appoints Michael Buhle as CEO, James Crawford as VP of Finance
--------------------------------------------------------------------------------

- Michael Buhle appointed CEO, adds role to current Chief Commercial Officer duties; effective Jan 28, 2025.
- James Crawford appointed VP of Finance, serving as principal financial and accounting officer; joined Aspira in 2021.
- Interim CEO Dr. Sandra Milligan remains President of the Company.
- No family relationships or material interests with existing directors or officers per Regulation S-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer